JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) — via InvestorWire — Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8th Annual Dawson James Small Cap Growth Conference on October 12, 2023, at the Wyndham Grand Hotel in Jupiter, FL.
Dawson James’ flagship Small Cap Growth Conference brings together senior leadership from over 30 of the most innovative companies at the forefront of healthcare, technology and consumer sectors. Now in its eighth year, attendees will include top institutional funds, prestigious family offices and high-net-worth investors.
The full-day event kicks off at 7:30am with registration and breakfast, followed by engaging corporate presentations from each company’s management team across two tracks starting at 8:00am. This proven format enables investors to learn about specific business models and opportunities while identifying potential synergies. Throughout the day, attendees of the Conference can schedule one-on-one meetings with presenting company executives. These one-on-one conversations consistently pave the way for long-lasting, fruitful partnerships.
Dawson James’ Conference offers a rare chance to overcome challenging headwinds by connecting corporate leaders with difficult-to-access growth capital and broader markets. It spotlights under-the-radar opportunities overlooked by traditional financiers, with an emphasis on high-demand healthcare, tech innovation and consumer solutions.
The conference concludes at 5:00 pm with a Closing Networking Reception, where attendees can expand business contacts in a relaxed atmosphere. With a diverse group of participants, this year’s conference promises to unlock new wealth creation avenues for investors and companies alike.
All are welcome to register for the 8th Annual Dawson James Small Cap Growth Conference to be held on Thursday, the 12th of October.
Please visit https://DawsonJames.com for details and registration information.
Participating Companies as of 09/19/2023
Company | Ticker | URL |
Aditxt, Inc. | NASDAQ: ADTX | https://www.aditxt.com/ |
Annovis Bio Inc. | NYSE: ANVS | https://www.annovisbio.com/ |
bioAffinity Technologies, Inc. | NASDAQ: BIAF | https://bioaffinitytech.com/ |
Bitfarms | NASDAQ: BITF | https://bitfarms.com/ |
Borqs Technologies, Inc. | NASDAQ: BRQS | https://www.borqs.com/ |
Citius Pharmaceuticals, Inc. | NASDAQ: CTXR | https://www.citiuspharma.com/ |
Clearmind Medicine Inc. | NASDAQ: CMND | https://www.clearmindmedicine.com/ |
Cyclo Therapeutics | NASDAQ: CYTH | https://cyclotherapeutics.com/ |
CytoSorbents Corporation | NASDAQ: CTSO | https://cytosorbents.com/ |
GeoVax Labs, Inc. | NASDAQ: GOVX | https://www.geovax.com/ |
HealthBeacon | OTCQX: HBCNF | https://healthbeacon.com/ |
Heartbeam, Inc. | NASDAQ: BEAT | https://www.heartbeam.com/ |
Hillstream BioPharma, Inc. | NASDAQ: HILS | https://hillstreambio.com/ |
Innovative Eyewear Inc | NASDAQ: LUCY | https://lucyd.co/ |
Inuvo Inc. | NYSE: INUV | https://inuvo.com/ |
JanOne, Inc. | NASDAQ:JAN | https://janone.com/ |
Janover Inc. | NASDAQ: JNVR | https://janover.co/ |
Kintara Therapeutics, Inc. | NASDAQ: KTRA | https://www.kintara.com/ |
Matinas Biopharma Holdings, Inc. | NYSE AMERICAN: MTNB | https://www.matinasbiopharma.com/ |
NextPlat Corp. | NASDAQ: NXPL | https://www.nextplat.com/ |
NovaBay Pharmaceuticals, Inc. | NYSE AMERICAN: NBY | https://novabay.com/ |
Neuro Rx Pharmaceuticals | NASDAQ: NRXP | https://www.nrxpharma.com/ |
Red Cat Holdings, Inc. | NASDAQ: RCAT | https://redcat.red/ |
SeaStar Medical Holding Corporation | NASDAQ: ICU | https://seastarmedical.com/ |
SKYX Platforms Corp. | NASDAQ: SKYX | https://skyplug.com/ |
Sonoma Pharmaceuticals, Inc. | NASDAQ: SNOA | https://sonomapharma.com/ |
STRATA Skin Sciences, Inc. | NASDAQ: SSKN | https://www.strataskinsciences.com/ |
Windtree Therapeutics, Inc. | NASDAQ: WINT | https://windtreetx.com/ |
Wisa Technologies | NASDAQ: WISA | https://www.wisatechnologies.com/ |
ZIVO Bioscience, Inc. | NASDAQ: ZIVO | https://www.zivobioscience.com/ |
Zomedica Corp. | NYSE AMERICAN:ZOM | https://zomedica.com/ |
About Dawson James Securities
With corporate offices located in Florida, Dawson James Securities also has offices in New York and Maryland. Dawson specializes in capital raising for small and microcap public and private growth companies primarily in the Life Science/Health Care, Technology and Consumer sectors and is a full-service investment banking firm with research, institutional and retail sales, as well as execution trading and corporate services.
Member FINRA/SIPC. For more information about the Conference, please contact:
Monique MacLaren
[email protected]
561-208-2939
Corporate Communications:
IBN (InvestorBrandNetwork)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]